Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
Source link
atOptions = {
'key' : '935d6ab39f70f5664bb173656c8b20f0',
'format' : 'iframe',
'height' : 250,
'width' : 300,
'params' : {}
};
